Neuroone Medical Technologies is trading at $2.28, up 6.05%, primarily as broader market sentiment strengthens with firmer U.S. futures.
- No new company-specific announcement was identified for August 21, 2026.
- The move follows recent volatility after August 13, 2026 fiscal Q3 results, including 16% year-over-year product-revenue growth and revised fiscal 2026 revenue guidance of $9.2 million–$10.5 million.
- Nasdaq futures were up 0.62% and S&P 500 futures 0.34%; earnings-related volatility may also be contributing.